BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts

Author: Lucas Aimee L.   Frado Laura E.   Hwang Caroline   Kumar Sheila   Khanna Lauren G.   Levinson Elana J.   Chabot John A.   Chung Wendy K.   Frucht Harold  

Publisher: Blackwell Publishing

E-ISSN: 1097-0142|120|13|1960-1967

ISSN: 0008-543X

Source: Cancer, Vol.120, Iss.13, 2014-07, pp. : 1960-1967

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content